Medicare Enrolled
Dr. Jose Mathew, DO, MPH
Pain Medicine (Physical Medicine & Rehabilitation) Physician · Lawrenceville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mathew from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mathew?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mathew
Dr. Jose Mathew is a pain medicine physician in Lawrenceville, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mathew performed 1,867 Medicare services across 970 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mathew received a total of $43,531 from 43 pharmaceutical and/or device companies across 542 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine (physical medicine & rehabilitation) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mathew is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 41% volume in GA
$43,531 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,867
Medicare services
Top 41% in GA for pain medicine (physical medicine & rehabilitation) physician
970
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~104 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
859 | $60 | $280 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
172 | $12 | $45 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
147 | $90 | $323 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
99 | $42 | $185 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
99 | $111 | $350 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
70 | $32 | $134 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
70 | $148 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $114 | $497 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
59 | $192 | $600 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
47 | $102 | $928 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
24 | $35 | $183 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
24 | $20 | $243 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
20 | $39 | $402 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
19 | $74 | $695 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
19 | $89 | $556 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
18 | $68 | $518 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
17 | $53 | $305 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
16 | $80 | $710 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $41 | $337 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
14 | $63 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$43,531
Total received (2018-2024)
Avg $6,219/year across 7 years
Top 6% in GA for pain medicine (physical medicine & rehabilitation) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
542
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23,377 (53.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,404 (44.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$750 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,746
2023
$4,189
2022
$6,774
2021
$6,600
2020
$1,906
2019
$2,870
2018
$18,445
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,266
Vertos Medical, Inc.
$533
Stryker Corporation
$277
Boston Scientific Corporation
$252
Curonix LLC
$153
Spinal Simplicity, LLC
$115
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$66
Collegium Pharmaceutical, Inc.
$41
SCILEX PHARMACEUTICALS INC.
$22
Nalu Medical, Inc.
$21
Top 3 companies account for 75.6% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$14,240
SCILEX PHARMACEUTICALS INC.
$4,755
Scilex Pharmaceuticals Inc.
$4,581
Medtronic, Inc.
$4,493
Nuvectra Corporation
$2,591
Medtronic USA, Inc.
$2,395
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,946
Relievant Medsystems, Inc.
$1,030
Abbott Laboratories
$774
HydroCision, Inc.
$750
Boston Scientific Corporation
$714
Vertiflex, Inc.
$686
Collegium Pharmaceutical, Inc.
$616
Nalu Medical, Inc.
$596
Vertos Medical, Inc.
$533
PAINTEQ LLC
$447
BOSTON SCIENTIFIC CORPORATION
$335
Curonix LLC
$318
Stryker Corporation
$277
Forte Bio-Pharma LLC
$194
Horizon Therapeutics plc
$190
FORTE BIO-PHARMA LLC
$166
Spinal Simplicity, LLC
$115
US WorldMeds, LLC
$104
Arteriocyte Medical Systems, Inc.
$97
PFIZER INC.
$79
Sentynl Therapeutics, Inc.
$73
Shionogi Inc
$70
Bioventus LLC
$51
Egalet US Inc
$38
DePuy Synthes Sales Inc.
$37
Novartis Pharmaceuticals Corporation
$31
BioDelivery Sciences International, Inc.
$27
ARBOR PHARMACEUTICALS, INC.
$27
Purdue Pharma L.P.
$23
USWM, LLC
$23
Radius Health, Inc.
$22
Stimwave Technologies Incorporated
$21
Kaleo, Inc.
$18
Horizon Pharma plc
$18
Almatica Pharma LLC
$12
Saluda Medical Americas, Inc.
$11
AstraZeneca Pharmaceuticals LP
$11
Top 3 companies account for 54.2% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · Algovita · Axium INS DRG IPG · BUNAVAIL 2.1 mg 30-count box · Belbuca · CLINICAL TRIAL PRODUCT · DUEXIS · Durolane · Evoke SCS · Evzio · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GRALISE · HA MINUTEMAN G3-R · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LYRICA · Levorphanol Tartrate · Lucemyra · Lucemyra/Lofexidine · MILD DEVICE KIT · MOVANTIK · MYSTIM · Magellan · Morphabond ER · Movantik · N'VISION · NALOCET · NO_PRODUCT · Nalocet · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OPTABLATE · ORTHOVISC · PAINTEQ · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · RAYOS · RELISTOR · RELISTOR ORAL · RESTORE · RoxyBond · SPECTRA WAVEWRITER · SPRIX · SUPERION · SYMJEPI · SYMPROIC · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Stimrouter Implantable Kit · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · TenJet · Tymlos · VANTA ADAPTIVESTIM · VECTRIS · XTAMPZA · XTAMPZAER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine (physical medicine & rehabilitation) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for pain medicine (physical medicine & rehabilitation) physician in GA.
Geographic Context
Pain medicine physicians within 10 mi
21
Per 100K population
2.2
County median income
$84,823
Nearest hospital
SUMMITRIDGE CENTER- PSYCHIATRY & ADDICTIVE MED
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mathew is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of GA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mathew experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mathew performed 859 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mathew receive payments from pharmaceutical companies?
Yes. Dr. Mathew received a total of $43,531 from 43 companies across 542 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mathew's costs compare to other pain medicine physicians in Lawrenceville?
Dr. Mathew's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mathew) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicine Physicians in Lawrenceville
Browse pain medicine physicians in Lawrenceville ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicine Physicians in GA
Pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicine Physicians in GA
Which GA pain medicine physicians receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
SCILEX PHARMACEUTICALS INC. Payments to Doctors
See all physicians who received payments from SCILEX PHARMACEUTICALS INC.
By company
Scilex Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Scilex Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology